Introduction {#S1}
============

In eukaryotic cells, 147 bp of DNA is tightly wrapped around a histone octamer, consisting of one copy of H3-H4 tetramer and two copies of H2A-H2B dimer, to form the nucleosome. In the "beads on a string" model, the repeating nucleosomes and flanking \"linker\" DNA form a 10-nm-fiber with histone H1 stabilizing the structure. It has been suggested that a chain of nucleosomes is further folded into a 30 nm fiber in the so called "solenoid" or "double start" structure ^[@R1]^. Many positively charged lysines in histones are believed to play critical roles in this packaging process by neutralizing the negative change of phosphate in the DNA. However, the nucleosome structure occludes DNA from many cellular processes, including transcription, DNA replication, and DNA repair. To enable dynamic access to the packaged DNA, cells have evolved a set of specialized chromatin remodeling complexes ^[@R2]^. One class of remodelers including SWI/SNF, ISWI, and CHD alters DNA packaging by sliding, ejecting, or re-organizing nucleosomes in an ATP-dependent manner. Another class achieves their function by adding or removing covalent modifications on histone tails. These post-translational modifications include methylation (me), acetylation (ac), monoubiquitylation (ub1), and *etc.* ^[@R3]^. Acetylation in particular negates the charge on ε-amino groups of lysine residues, therefore changing chromatin folding as the direct consequence of altering the histone-DNA or histone-histone electrostatic interactions. Some histone modifications exert their remodeling effects by recruiting chromatin remodeling factors. Importantly, acetylation can have both effects as it serves as a recognition site for the bromodomain, a motif common in ATP-dependent remodelers.

It has been known for more than 40 years that there are multiple acetylation sites in the four core histones ^[@R4]^. The levels of acetylation are regulated by two opposite enzymatic reactions that either transfers or removes the acetyl moiety of acetyl-CoA to the ε-amino group of lysine side chains. These reversible processes are performed by histone acetyltransferases (HATs) and histone deacetylases (HDACs) ^[@R5]^. Acetylation has long been associated with transcriptional activation and HATs have been identified as transcriptional co-activators. In contrast, histone deacetylation is generally thought to play roles in transcriptional repression and HDACs have been identified as transcriptional co-repressors ^[@R6]^. Numerous *in vitro* acetylation assays and *in vivo* gene inactivation studies in past decades have suggested the existence of a specific regulatory mechanism based on the substrate specificity of HATs ^[@R7]^. Based on these results, one would expect diverse genomic distribution patterns for different histone acetylation marks accompanied with preferential binding of each HAT or several HATs as the results of substrate specificity. On the contrary, the genome-wide mapping of 18 acetylation marks showed that they were targeted to enhancers, promoters, and actively transcribed gene bodies with only subtle differences ^[@R8]^. Also, the same approach demonstrated five HATs (p300, CBP, MOF, PCAF, and Tip60) and four HDACs (HDAC1, 2, 3, and 6) were recruited to the hyperacetylated regions ^[@R9]^, contradicting to previous findings that HDACs are targeted primarily to transcriptionally inactive regions. In addition to the localization in active genes, HATs and HDACs were found to be transiently recruited to poised genes marked by H3K4 methylation for future activation ^[@R9]^.

Beyond studying their modifying enzymes or genomic locations, analyzing the kinetics of these modifications has been proven to be very informative. We and others have measured the site specific kinetics of histone methylation by quantitative mass spectrometry using stable isotope labeled methionine as a tracer ^[@R10]--[@R14]^. Because methionine can be metabolized to *S*-adenosyl methionine, the direct methyl group donor for the methylation reaction, the labeling is very efficient. By contrast, labeling acetylation is more difficult since cells use multiple metabolic pathways to generate acetyl-CoA. Dozens of studies in the past 30 years have used radioactive acetate as a tracer to estimate the turnover of acetylation on whole histones ^[@R15]--[@R17]^. As summarized by Waterborg, these studies identified fast (half-life of few min.) and slow turnover rates (half-life of \~30 min.) in all four core histones from yeast to plant and animal cells ^[@R18]^. However, these results provided an estimation of overall acetylation turnover in each core histone without site-specific information. In addition, these rates appear faster than would be needed to account for the rate observed for transcription ^[@R18]^.

To address these issues, we developed a new metabolic labeling method to study acetylation kinetics at specific lysines using quantitative target mass spectrometry via selective reaction monitoring (SRM) ^[@R14]^. This first report of acetylation half-lives is selective for pools of old histone by virtue of a double labeling scheme and revealed a subset of sites that are surprisingly long-lived.

Results {#S2}
=======

Measurement of acetylation turnover in old histone {#S3}
--------------------------------------------------

Acetyl-CoA is generated from multiple sources, including glucose, pyruvate, glutamine, and fatty acids. Using mammalian cells in culture, the main source of acetyl-CoA for histone acetylation was found to be citrate generated during glucose metabolism ^[@R19]^. Therefore, we used ^13^C~6~ -- glucose (simply referred to here as 'heavy glucose') as a source of isotope tracers that via acetyl-CoA would be introduced into the acetyl groups of histones ^[@R20]^. However, the other sources of acetyl-CoA mean that only some fraction of the acetyl-CoA pool can be labeled by a single source, hence lowering the observed appearance rate of new acetyl groups. However, this effect can be mathematically modeled and the true appearance rate determined for reaching steady-state levels of labeled acetylation (Methods). We also investigated labeling using 2,3 ^13^C~2~ -- pyruvate (see below), but only achieved \~70% the labeling level of glucose which itself was near 80% ([Supplementary Fig. S1](#SD1){ref-type="supplementary-material"}). Both reagents will be converted to acetyl-CoA with a +2 Da "label" in acetyl groups that is transferred to lysine side chains ([Fig. 1b](#F1){ref-type="fig"}). Our labeling scheme as shown in [Figure 1a](#F1){ref-type="fig"} includes two labeling steps. First, histones were exhaustively labeled by growing in media containing ^13^C~6~ -- arginine for 7 days to label \>90% histones so each of tryptic peptide produced from histones derivatized with propionic anhydride carries a +6 Da mass shift ^[@R14]^. Second, cells were then switched to the media with regular arginine and heavy glucose (not supplemented with pyruvate or glutamine). After the media switch, all the acetylation being installed before the switch will have light acetyl group (referred as old ac) while the new acetylation will carry a +2 Da acetyl group (referred as new ac) in an ideal condition when acetyl-CoA is 100% labeled. Given the metabolic complexities of new histone synthesis on mixed isotopes, we limited our measurements to old histone that was synthesized before the media switch to track the rate of old acetyl groups being replaced by new ([Supplementary Methods](#SD1){ref-type="supplementary-material"}).

Appearance of new acetyl in H3K14ac but not in H3K4ac {#S4}
-----------------------------------------------------

Different from the "SILAC" approach where stable isotopes are used to measure protein expression ratios ^[@R21]^, we used them here to distinguish old vs. new histone ^[@R22]^ while also initiating a temporal pulse of new acetyl-CoA in live cells ([Fig. 1a](#F1){ref-type="fig"}). As shown in [Figure 2a](#F2){ref-type="fig"}, a fast appearance of new acetyl was observed in H3K14ac from old histone when the K9 in the same peptide was unmodified (H3K9un-K14ac). The +2 Da mass shift in new acetyl allows discrimination of new from old acetylation even in the 30 h sample with the least intense signals of all the six time points. This decrease in absolute intensity was due to dilution of old histone as the synthesis of new histone builds, consistent with previous observations ^[@R14]^. Showing a striking difference at the other extreme, no new acetyl was observed for H3K4ac ([Fig. 2b](#F2){ref-type="fig"}). The background level of noise for H3K4ac with new acetyl was steady over the entire 30 h time course. Since histone peptides from similar cell numbers were subjected to nLC-QqQ MS analysis, the fast increase of new acetylation accompanied by the fast decrease of old acetylation indicated a fast rate of turnover for H3K14ac.

Fast increase of new acetyl in a subset of acetylation sites {#S5}
------------------------------------------------------------

To account for slight variations in absolute loading amounts, two types of normalization schemes, called relative levels and distributive levels, were used in this paper (see formulas in the Methods section). Relative level is the signal for a new acetylation for a particular site normalized against the signals from all the modification states of the peptide that harbors that site (old histone only); distributive levels are simply the ratio of new vs. (new + old) acetylation signals at a particular site. As shown in [Figure 3a](#F3){ref-type="fig"}, the relative levels of new acetylation determined for the 19 acetylation sites demonstrated two general types of behavior. Ten of the sites showed robust increases in new acetylation: H3K9, H3K14, H3K18, H3K23, H3.1/2-K27, H3.3-K27, H2AK5, H2AK9, H4K5, and H4K16. The stable level of acetylation labeling at these sites ranged from 30--80% and was reached within 6 h for all ten sites. By contrast, no appearance of new acetylation was observed for the other 9 acetylation sites ([Fig. 3a](#F3){ref-type="fig"}; distributive levels are shown in [Fig. 3b](#F3){ref-type="fig"} for all sites measured).

System Response and Background Levels {#S6}
-------------------------------------

The relative levels of all 19 sites showed a slight dip in the second time point (*i.e.*, t=45 min.) after the switch to new media at time zero. ([Fig. 3a](#F3){ref-type="fig"}). Some sites reached stable levels immediately after the 90 min. point (such as H3K9 and H3K23), while other sites rose back more gradually to their stable levels (such as H3K18 and H2AK5). This slight dip in relative acetylation levels seems related to the experimental procedure of media change and buffer washing necessary for removal of heavy arginine and regular glucose present in the old media; an exact explanation will require further investigation. It is also worth noting that initial new acetylation levels are theoretically zero. Therefore, the observed presence of signal for new acetylation in several sites (*e.g.*, H3.1/2-K27ac, H3.3-K27ac, H3.3-K36ac, H3K79ac, and H3K122ac) represent a baseline signal from unknown sources at \~10%; background levels for the other sites were \<5% ([Fig. 3b](#F3){ref-type="fig"}).

Site-specific half-life of histone acetylation turnover {#S7}
-------------------------------------------------------

As shown in [Figure 3b](#F3){ref-type="fig"}, three different kinetic patterns were found in the graphs of distributive levels and were therefore used to categorize acetylation sites. Group I, the 10 sites with fast increases of new acetylation levels (relative and distributive), had half-lives ranging from 0.8 to 2.3 h ([Table 1](#T1){ref-type="table"}; also see Methods and [Supplementary Fig. S2](#SD1){ref-type="supplementary-material"} for details of data fitting). It is worth noting that labeled population is only equal to the labeling efficiency of acetyl-CoA pool when all the population of this site is turned over. The fact that the labeled population varied among sites suggests the likely existence of the sub-population with very low or no turnover in those sites having low levels of labeled population (such as H3K27ac).

The acetylation sites H4K20 and H3.3-K36 exhibited a distinct behavior and were therefore classified separately as Group II ([Fig. 3](#F3){ref-type="fig"}). At these sites, there is a sharp reduction in the overall acetylation level, yet no appreciable new acetylation detected (see [Fig. 3](#F3){ref-type="fig"} panels for H4K20 and H3.3-K36). Also at these sites, increasing methylation contributed in part to the observed decrease of overall acetylation signal ([Supplementary Methods](#SD1){ref-type="supplementary-material"}). For Group III containing 7 sites ([Table 1](#T1){ref-type="table"}), no change of distributive levels of new acetylation was observed (*i.e.*, no evidence for acetylation turnover in the 30 hour experiment; see [Fig. 3b](#F3){ref-type="fig"}). To further confirm our findings, we performed the same experiment using heavy pyruvate as the tracer. Despite dropping a few sites in the assay due to a lower labeling efficiency (\~60% vs. 80% for glucose) and higher noise levels, the overall trend is similar ([Supplementary Fig. S1](#SD1){ref-type="supplementary-material"}). It is worth noting that all the peptides from histone H3 except H3K27-K36 were conserved among the three H3 variants (H3.1, H3.2, and H3.3); therefore results reported here represent the average turnover for these 3 variants. The levels determined are shown in [Table 1](#T1){ref-type="table"} and ranked according to their turnover rate within Group I.

Butyrate-induced acetylation is restricted to Group I sites {#S8}
-----------------------------------------------------------

To confirm our findings, we measured histone acetylation levels for all 19 sites in response to broad spectrum HDAC inhibition. Both relative levels and fold changes were reported and the results shown in [Supplementary Fig. S3](#SD1){ref-type="supplementary-material"} for the time course data obtained from cells treated with sodium butyrate. To avoid secondary effects from cell cycle arrest caused by butyrate treatment, the fold change of acetylation levels in 6 h of treatment was used in [Table 1](#T1){ref-type="table"} for comparison to rates of turnover. Strikingly, only Group I sites showed between 2 and 10 fold increases in acetylation stoichiometry. In addition, the response to butyrate treatment showed a similar trend to the half-lives of fast turnover sites ([Fig. 4a](#F4){ref-type="fig"}). All the Group III sites with no turnover showed \<1.1 fold or lower response to butyrate. This strongly corroborates our kinetic findings that turnover of these sites is in fact extremely low.

Discussion {#S9}
==========

An overall summary of the rates of acetylation turnover mapped onto sites on histone tails is provided in the [Figure 5](#F5){ref-type="fig"} diagram. No correlation between turnover rate and the normal levels of acetylation was found except that the three most abundant acetylation sites (H3K14ac, 28%; H3K23ac, 25%; H4K16ac, 36%) all had fast turnover. Other than that, turnover rates for sites with low acetylation stoichiometry could be found in all three different groups ([Table 1](#T1){ref-type="table"} and [Fig. 4b](#F4){ref-type="fig"}).

Genome wide mapping of HATs and HDACs by ChIP-seq have shown both of them are enriched in active genes and appear to positively correlate with transcription levels ^[@R9]^. This suggests the removal of acetylation in active genes to reset chromatin modification after gene transcription. Such observations are consistent with a well-established model in *S. cerevisiae* where the Rpd3S histone deacetylase complex is recruited to H3K36me2/3-decorated chromatin (methylated by Set2) to deacetylate nucleosomes behind elongating RNA Pol II to prevent cryptic initiation of transcription within the coding region ^[@R23]^. In addition to deacetylation of nucleosomes within the gene body, the Set3C histone deacetylase complex can also be recruited by H3K4me2 (methylated by Set1) to deacetylate 5' transcribed regions ^[@R24]^. Different from yeast HDAC complex, the mammalian counterpart lacks the chromodomain for the direct targeting to H3K36me2/3 chromatin. However, both Tip60 and HDAC6 can be targeted to active genes through the interaction with Pol II ^[@R9]^.

The likely outcome of targeting both HDACs and HATs to actively transcribed genes will be a high turnover rate of histone acetylation in these regions. Indeed, we observed very fast turnover in 12 acetylation sites (Group I and II, in [Table 1](#T1){ref-type="table"}) with half-lives ranging from 0.8 to 2.3 h. In addition, all these marks except H4K20ac have been shown to be localized in promoters/enhancers, and/or active transcribed gene bodies with positive correlations to transcriptional activity ^[@R8]^. As mentioned in the Introduction, previous pulse/chase studies using radioactive acetate have determined overall acetylation of H3 and H4 to be as fast as 2--3 min. in the fast phase and \~30 min. in the slow phase. Considering the transcriptional elongation rate of 0.3--0.8 kb/min. determined in mammalian cells by imaging the transcription of a single gene ^[@R25]^, it takes \~6--15 min. to transcribe through a 5 kb small gene. With the additional time required for transcription initiation, it is improbable for one cycle of removal of acetylation in the gene bodies for all the genes to be as fast as several minutes. Therefore, it is possible that previous studies using radioactive acetate selectively labeled histones in highly transcribed genes during the short pulse due to a limited pool of labeled acetyl-CoA. This contrasts with our half-lives, determined with steady-state levels of acetyl-CoA as indicated by the stable population of labeled histones at each lysine in Group I. As shown in [Figure 3b](#F3){ref-type="fig"}, the highest labeling efficiency is \~80%, implying that at least 80% of acetyl-CoA pool is labeled by the glucose labeling scheme reported here.

Seven sites showed no significant increase of new acetylation or decrease of old acetylation and were categorized as Group III as "no detectable turnover". Except H3K4ac and H3K56ac, there are precious few functional studies to draw from for these Group III sites. Genome wide mapping studies of H3K4ac in both human and *S. cerevisiae* have determined H3K4ac is localized at active gene promoters ^[@R8],[@R26]^. A genetic screen in yeast has determined deacetylation of H3K4 is mainly performed by Hst1 and Sir2 (to lesser extent) in euchromatin, and only dependent on Sir2 in heterochromatin ^[@R26]^. Importantly, both Hst1 and Sir2 are NAD-dependent deacetylases belonging to the class III HDAC family. Acetylation within the globular core domain of histone H3 on K56 has been shown to have a critical role in packaging DNA into chromatin following DNA replication and repair in budding yeast ^[@R27]^. Similar to H3K4ac, deacetylases of H3K56ac are also known to be NAD-dependent class III HDACs, namely Hst3 and Hst4 ^[@R28],[@R29]^. Very interestingly, a puzzling result has been reported recently that levels of H3K56ac were not affected by all the tested HDAC inhibitor targeting class I/II or class III ^[@R30]^. This result can be explained by our observation of extremely slow turnover of H3K56ac. In addition to Group III sites, some Group I sites might also have stable subpopulations. For example, H3K27ac from both canonical H3.1/2 and the H3.3 variant showed low labeling levels (30% and 20%, respectively), suggesting more than half of K27ac could be stable.

The observation that acetylation turnover could be 2 fold faster when adjacent sites are both acetylated (*i.e.*, for K9/K14 on H3) but \~50% slower when the neighboring site was methylated ([Supplementary Fig. S4](#SD1){ref-type="supplementary-material"}) highlights the regulatory effects of nearby modifications. Such observations can be explained by either promiscuous behavior of HATs and HDACs, or intentional recruitment or occlusion of such enzymes at specific genomic locations. The higher turnover of dual-acetylated H3 at both K9 and K14 could be caused by higher local HAT/HDAC concentrations in the chromatin region where they are present. In addition, the observation of H3.3 variant-specific K36ac suggested that its cognate HAT/HDAC pair(s) have superior substrate specificity capable of discriminating the single amino acid changed among the H3 variants in this region of sequence (localized 5 residues away from K36; see [Fig. 5](#F5){ref-type="fig"}, [Supplementary Fig. S5a and Supplementary Methods](#SD1){ref-type="supplementary-material"}). With more genetic alterations of HATs being identified in cancers and the use acetylation modulators (*e.g.*, HDACi, HAT inhibitors, bromodomain inhibitors) increasing in cancer research ^[@R31]^, the results described here provide a new context to understand and measure the pharmacokinetic behavior of different acetylation sites *in vivo*.

The importance of acetylation is not limited to histones, as it appears as widespread as phosphorylation in intracellular signalling ^[@R32]^. It should not escape our attention that high efficiency metabolic labeling of acetyl-CoA provides a useful tool for functional studies of protein acetylation generally. For example, what is the turnover rate of acetylation in p53 when DNA damage is induced?

Methods {#S10}
=======

Stable isotope tracer labeling and sample preparation {#S11}
-----------------------------------------------------

HeLa S3 cells were grown in adherent for 7 days at 37 °C in heavy DMEM media (omission of arginine, AthenaES) supplemented with \[^13^C~6~\]arginine (99% enriched, Cambridge Isotope Laboratories) and 10% dialyzed fetal bovine serum (FBS) before release into glucose and sodium pyruvate free DMEM plus 10% dialyzed FBS supplemented with \[^13^C~6~\]glucose (2 g/l, 99% enriched, Cambridge Isotope Laboratories) or \[2,3 -^13^C~2~\] pyruvate (10 mM, 99% enriched, Cambridge Isotope Laboratories). Cells were washed twice with phosphate buffered saline to remove old media before releasing cells into new media. Stable isotope labeled cells were harvested at time points of 0, 0.75, 1.5, 3, 6, and 30 h after the media switch and 5 mM sodium butyrate treated cells at 0, 1.5, 3, 6, and 24 h before collection and flash freezing in liquid N~2~. Histones from acid extraction of isolated nuclei were derivatized using propionic anhydride and digested with trypsin, as described previously ^[@R14],[@R33]^.

Nano LC QqQ MS {#S12}
--------------

The digested and derivatized histone peptides were diluted in 0.1% TFA and injected to naon-LC-QqQ MS (Dionex nanoLC and a ThermoFisher Scientific TSQ Quantum). Peptides were first loaded to a trapping column (2 cm×150 µm) and then separated with an analytical capillary column (10 cm×75 µm). Both were packed with Magic C18 resin (Michrom). The chromatograph gradient was achieved by increasing percentage of buffer B from 2 to 35% at a flow rate of 0.35 µl/min (A: 0.1% formic acid, B: 0.1% formic acid in acetonitrile) over 40 minutes. The peptides were then introduced into QqQ MS by electrospray from an emitter with 10 µm tip (New Objective) as they were eluted from capillary column. The QqQ settings were as follows: collision gas pressure of 1.5 mTorr; Q1 peak width of 0.7 (FWHM); cycle time of 3.5 s; skimmer offset of 10 V; electrospray voltage of 2.6 kV.

SRM method development and mass spectral data analysis {#S13}
------------------------------------------------------

SRMs capable of discriminating 19 acetylation sites from 13 different histone peptides were developed with two to four fragment ions for each species. Various histone peptides with different modifications were purchased or custom synthesized from Anaspec or Genescript to assist the method development. Data were analyzed in Skyline with Savitzky-Golay smoothing ^[@R34]^. All labeled and unlabeled peaks were grouped as a whole for manual peak determination to avoid bias. Total peak areas from SRM were used for quantification (as listed in [Supplementary Table S1](#SD1){ref-type="supplementary-material"}).

Peptide nomenclature and data handling {#S14}
--------------------------------------

All the peptides with their modifications that were quantified in this study are listed in [Supplementary Table S1](#SD1){ref-type="supplementary-material"}. In this paper, we simply used the position of lysine that can be acetylated in the protein to refer the peptide. For example, T~3~KQTAR~8~ was referred to as the "H3K4 peptide" and K~9~STGGKAPR~17~ as the "H3K9-K14 peptide". For the purpose of determining acetylation turnover, three forms were measured for the peptide targeted by mono-acetylation (H3K56, H3K122, and H2AK36): unmodified (chemical derivatized by propionylation, +56 Da) and acetylated (light and heavy, +42 and +44 Da); six forms were measured for the peptide targeted by both acetylation (ac) and methylation (me) to the single lysine: unmodified, acetylated (light and heavy), me1, me2, and me3 (H3K4, H3K79, and H4K20); nine forms were measured for the peptide targeted by di-acetylation to two lysines (H3K18-K23, H2AK5-K9, and H2AK13-K15); 18 forms were measured for H3K9-K14 (K9 is methylated and acetylated, K14 is acetylated). Multiple channels of measurement were aggregated together for each site for those peptides with many modification states. For example, 5 channels of K14ac, with K9 carrying un, me1, me2, me3, or ac, were summed together to represent the total level of K14ac. Finally, for histone H4 we only measured H4K5ac and H4K16ac because the two internal acetylation sites (H4K8ac and H4K12ac) were difficult to measure with SRM. $$\text{Distributive\ level} = \text{new\ acetylation}/(\text{new} + \text{old\ acetylation})$$ $$\text{Relative\ levels} = \text{new\ acetylation}/\text{all\ modifications\ on\ peptide}$$ Two quantification schemes were used in this study, differed simply by which pool of peptides was used to normalize the signal for any given acetyl mark ^[@R10],[@R14]^. Distributive level is the term used to refer to the normalization of heavy acetylation within acetylation of each site (i.e., the signal of heavy ac is divided by the combined signal of heavy plus light ac). Relative level is used to indicate signals from all the modification species found at a particular site are summed as total (ac site: unmodified + light ac + heavy ac; ac + me site: unmodified + me1 + me2 +me3 + light ac + heavy ac). Recall that heavy acetylation is new and light acetylation is old.

Determination of acetylation turnover rates and half-lives {#S15}
----------------------------------------------------------

An exponential decay model with 3 parameters was used to fit the data in Group I using the distributive levels of new acetylation (with all 6 time points). In the equation, new acetyl = p\* (1-exp(-k\*t))+n, p represents the labeled pool of acetylation in each site, k for the turnover rate, and n for the noise (initial value is not zero; see [Supplementary Fig. S2a](#SD1){ref-type="supplementary-material"}). The curve fitting was implemented by the cftool software package in Matlab (version 7.10). A different model (total acetylation = a\* exp(-k\*t)+c) was used to fit the data in Group II using relative levels of total acetylation, where parameter a is for initial level of acetylation in old histone, c for stable level of acetylation, and k for the turnover rate of deacetylation ([Supplementary Fig. S2b](#SD1){ref-type="supplementary-material"}). The half-life of turnover is calculated by ln2/k.
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![Schematic of experimental workflow for the measurement of histone acetylation turnover\
**(a)** The approach involves two steps of stable isotope labeling to detect old versus new acetylation events specifically on old histones. The workflow begins with exhaustive labeling of cells in heavy arginine media to label the histone backbone (depicted as a dark oval), followed by media exchange to label newly installed acetyl groups in lysine residues. Time points are taken and the material subjected to quantitative MS analysis of histone peptides. Detection of old acetylation corresponding to a light acetyl group (depicted as a light triangle) and new acetylation with a heavy acetyl group (depicted as dark triangle) is followed by fitting the data to an exponential model to calculate acetylation turnover rate for each site. **(b)** Stable isotope labeled glucose (or sodium pyruvate) was converted to labeled acetyl-CoA by primary metabolism.](nihms499252f1){#F1}

![Appearance of new acetylation on histone peptides detected by quantitative mass spectrometry\
Shown on the y-axes are the raw intensity values determined from the mass spectrometric data. The temporal profile for signals corresponding to old (blue) vs. new (red) acetylation on the H3K9un-K14ac **(a)** and H3K4ac **(b)** peptides exhibiting fast and no turnover, respectively. Both old and new acetylation were quantified using total area from 3 pairs of transitions (*i.e.*, precursor → fragment).](nihms499252f2){#F2}

![Appearance of new acetyl group in 19 acetylated lysines using ^13^C~6~ -- glucose as a tracer\
**(a)** Relative levels of both new acetylation (occurred after the media switch; blue diamonds) and all acetylation (both old and new; red squares) in 19 acetylated sites. These levels were determined by normalizing against overall signal from all measured modfied species (see Methods). (**b)** Distributive levels of new acetylation for 19 acetylated sites were determined by divding the peak area of new acetylation by that of total acetylation present at each particular site. The ten fast sites reaching a steady plateau are shown in upper panel, while the sites with no detectable new acetylation are displayed in the lower panel. Data from two biological replicates with three technical replicates of each were reported with SEMs shown as error bars.](nihms499252f3){#F3}

![Correlaton analyses of acetylation half-lives\
**(a)** Half-lives of acetylation sites with fast turnover correlated with their response to treatment with sodium butyrate. **(b)** Correlation of T~1/2~ values with the absolute stoichiometry of acetylation for each site. Note that half-lives for sites with undetectable turnover were all set to \>30 hour (x-axis, lower right). Both vertical and horizontal error bars indicate the standard deviation from their respective analyses.](nihms499252f4){#F4}

![Summary of acetylation turnover rates at 19 distinct lysine residues within core histones\
Illustrations showing known lysine acetylation sites in four core histones as 'K' followed by amino acid residue number. The globular domains are marked by grey bars. Fast turnover sites are overlaid with green and blue arrows for Group I and II sites, respectively. Stable sites (Group III) are indicated by red stop signs. Sites not measured in this study are labeled as ND.](nihms499252f5){#F5}

###### Site specific acetylation turnover and half-lives for 19 acetylation sites in core histones

Turnover in Group I sites were determined by fitting distributive levels of new acetylation with an exponential model and ranked according to the half-life (from small to large). Mean from two independent fittings of two biological replicates was determined and the standard deviation shown inside parenthesis. Acetylation and methylation (if present) stoichiometry were determined from unlabled asynchronous HeLa cells. For H3 variant specific sites (*e.g.*, H3.3 K36), stoichiometry was calculated within H3.1/2 or H3.3 variants. Turnover values in Group II sites were determined by fitting relative levels of overall acetylation with an exponential model. No detectable turnover was found for sites in Group III, and they were ranked according to their acetylation stoichiometry.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Group   Rank         Ac\             Turnover Rate\   T~1/2~\               Labeled\        Ac\       Overall\                                  Resp.\
                       Site            (h^−1^)          (h)                   Population      Stoich.   Me\                                       to Buty.\
                                                                                                        Stoich.[\*](#TFN1){ref-type="table-fn"}   (fold\
                                                                                                                                                  change)[\*\*](#TFN2){ref-type="table-fn"}
  ------- ------------ --------------- ---------------- --------------------- --------------- --------- ----------------------------------------- -------------------------------------------
  I       1            H2AK9           0.82 (± 0.09)    0.8 (± 0.1)           0.67 (± 0.02)   0.9%      N/A                                       10.8

  2       H3K14        0.67 (± 0.08)   1.0 (± 0.1)      0.591 (± 0.006)       27.8%           N/A       2.49                                      

  3       H3K18        0.65 (± 0.07)   1.1 (± 0.1)      0.698 (± 0.005)       4.1%            N/A       5.6                                       

  4       H3K23        0.64 (± 0.09)   1.1 (± 0.1)      0.67 (± 0.01)         25.1%           N/A       2.4                                       

  5       H3.3 K27     0.61 (± 0.02)   1.1 (± 0.1)      0.187 (± 0.008)       2.7%            58%       3.9                                       

  6       H2AK5        0.6 (± 0.2)     1.3 (± 0.4)      0.497 (± 0.006)       9.9%            N/A       3.4                                       

  7       H4K16        0.4 (± 0.2)     1.7 (± 0.8)      0.6 (± 0.2)           35.7%           N/A       2.14                                      

  8       H3K9         0.4 (± 0.1)     2.0 (± 0.5)      0.4927 (± 0.008)      2.2%            60%       4.5                                       

  9       H4K5         0.36 (± 0.07)   2.0 (± 0.4)      0.42735 (± 0.00007)   12.7%           N/A       4.7                                       

  10      H3.1/2 K27   0.32 (± 0.08)   2.3 (± 0.6)      0.308 (± 0.009)       1.5%            70%       4.5                                       

  II      1            H4K20           1.1 (± 0.9)      1.0 (± 0.8)           N/A             0.2%      95%                                       0.68

  2       H3.3 K36     0.6 (± 0.2)     1.2 (± 0.4)      N/A                   6.9%            81%       1.2                                       

  III     1            H2AK13          undetectable     6.4%                  N/A             1.01                                                

  2       H2AK36       3.7%            N/A              1.0                                                                                       

  3       H3K4         3.6%            16%              1.1                                                                                       

  4       H2AK15       3.2%            N/A              1.1                                                                                       

  5       H3K79        3.1%            29%              0.78                                                                                      

  6       H3K56        2.5%            N/A              0.86                                                                                      

  7       H3K122       1.9%            N/A              1.0                                                                                       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Overall methylation stoichiometry: the percentages shown for each lysine site were calculated by summing all forms of methylation together (me1 + me2 + me3).

Fold change of acetylation stoichiometry was determined in response to sodium butyrate at 0 vs. 6 hours (full data set shown in [Supplementary Fig. S3c](#SD1){ref-type="supplementary-material"}).
